Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair-Reference-Cited by-同舟云学术

Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair

Published:2020-09-07 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Fan Zhuoyi¹,Luo Huacheng²,Zhou Jie¹,Wang Fangce¹,Zhang Wenjun¹,Wang Jian³,Li Shuo⁴,Lai Qian⁵,Xu Yueshuang⁶,Wang Guangming¹,Liang Aibin¹,Xu Jun³

Affiliation:

1. Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, P.R.�China

2. Division of Pediatric Hematology/Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

3. East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R.�China

4. Jake Gittlen Laboratories for Cancer Research, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

5. Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Fujian 361003, P.R. China

6. Department of Pathology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key molecular DNA damage responses of human cells to radiation;Frontiers in Cell and Developmental Biology;2024-07-10

2. Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1;Pharmacological Research;2024-03

3. DNA Double-Strand Break Repair Inhibitors: YU238259, A12B4C3 and DDRI-18 Overcome the Cisplatin Resistance in Human Ovarian Cancer Cells, but Not under Hypoxia Conditions;Current Issues in Molecular Biology;2023-09-28

4. Studying the DNA damage response pathway in hematopoietic canine cancer cell lines, a necessary step for finding targets to generate new therapies to treat cancer in dogs;Frontiers in Veterinary Science;2023-08-16

5. Wee1 promotes cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1;Cell Communication and Signaling;2022-12-27